Connect your AI

OrthoPediatrics KIDS Restructuring Reserve

Restructuring Reserve at other companies

IAR

Integra LifeSciencesIART

——

EnovisENOV

——

Other financials

Income statement

Revenue$59.4M+13.3%

Gross profit$43.4M+13.4%

Operating income-$8.3M+24.1%

Net income-$10.7M-0.3%

EPS (diluted)-$0.45+2.2%

Balance sheet

Cash & equivalents$14.2M-59.8%

Total debt$5.4M+271%

Total equity$338.7M-2.4%

Total assets$502.2M+6.8%

Cash flow

Operating cash flow-$3.3M+20.9%

CapEx$1.8M-58.4%

Free cash flow-$5.0M+39.8%

Valuation

Market cap$503.94M+0.3%

Enterprise value$495.11M+5.7%

P/S2.1×-0.3×

Profitability

Gross margin73.1%+0.3pp

Operating margin-15%-1.6pp

Net margin-16.3%-2.1pp

FCF margin-12.9%-4.3pp

Returns & leverage

Return on equity-11.6%+0.2pp

Debt / equity0×0.0×

Current ratio5.2×-1.0×

Where this comes from

Reported directly by OrthoPediatrics in its filing.

Tagged under the XBRL concept us-gaap:RestructuringReserve.

The official record: OrthoPediatrics’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about OrthoPediatrics's restructuring reserve.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is OrthoPediatrics's restructuring reserve?: OrthoPediatrics (KIDS) reported restructuring reserve of $656K in Q1 2026.
How has OrthoPediatrics's restructuring reserve changed year-over-year?: OrthoPediatrics's restructuring reserve increased by 10.1% year-over-year, from $596K to $656K.